E. Siedek

发表

Efficacy of maropitant for preventing vomiting associated with motion sickness in dogs

T. Rowan, N. Tilt, H. Benchaoui, 2007, Veterinary Record.

Isolation and characterisation of equine dendritic cells.

A. Hamblin, N. Edington, E. Siedek, 1997, Veterinary immunology and immunopathology.

Equine macrophage identification with an antibody (Ki-M6) to human CD68 and a new monoclonal antibody (JB10).

A. Hamblin, E. Siedek, S. Mayall, 2000, Journal of comparative pathology.

EFFICACY AND SAFETY OF MAVACOXIB IN COMPARISON WITH CARPROFEN IN THE TREATMENT OF PAIN AND INFLAMMATION ASSOCIATED WITH DEGENERATIVE JOINT DISEASE IN DOGS PRESENTED AS VETERINARY PATIENTS

J. Mitchell, H. Six, J. Tena, 2012 .

Vaccination of dogs with canine parvovirus type 2b (CPV-2b) induces neutralising antibody responses to CPV-2a and CPV-2c.

J. Salt, C. Stirling, J. Illambas, 2014, Vaccine.

Vaccination with canine parvovirus type 2 (CPV-2) protects against challenge with virulent CPV-2b and CPV-2c.

R. Raue, G. Sture, E. Siedek, 2011, Berliner und Munchener tierarztliche Wochenschrift.

Equine herpesvirus type 1 infects dendritic cells in vitro: stimulation of T lymphocyte proliferation and cytotoxicity by infected dendritic cells.

M. Whelan, A. Hamblin, N. Edington, 1999, Veterinary immunology and immunopathology.

Epidemiology of Toxascaris leonina infection post-weaning within a colony of dogs

M. Fisher, M A Fisher, M G Murphy, 2002, Journal of Helminthology.

Efficacy of selamectin against experimentally induced and naturally acquired ascarid (Toxocara canis and Toxascaris leonina) infections in dogs.

D. Bowman, T. Rowan, A. D. Jernigan, 2000, Veterinary parasitology.

The anti-emetic efficacy of maropitant (Cerenia) in the treatment of ongoing emesis caused by a wide range of underlying clinical aetiologies in canine patients in Europe.

T. Rowan, N. Tilt, H. Benchaoui, 2007, The Journal of small animal practice.

A new multivalent (DHPPi/L4R) canine combination vaccine prevents infection, shedding and clinical signs following experimental challenge with four Leptospira serovars.

Ludmila Chromá, J. Salt, C. Stirling, 2013, Vaccine.

Duration of immunity of a multivalent (DHPPi/L4R) canine vaccine against four Leptospira serovars.

Ludmila Chromá, J. Salt, C. Stirling, 2013, Vaccine.

Equine dendritic cell infection with equid herpesvirus type 1 reduces their ability to support mitogenic T cell proliferation.

A. Hamblin, N. Edington, E. Siedek, 1997, Biochemical Society transactions.

The administration of a single dose of a multivalent (DHPPiL4R) vaccine prevents clinical signs and mortality following virulent challenge with canine distemper virus, canine adenovirus or canine parvovirus

J. Salt, C. Stirling, J. Illambas, 2014 .